SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
724Ouch. Another bad acquisition for a biotech. otoh cleaning up shop always makes rkrw-12/15/2006
723Costs Associated with Exit or Disposal Activities Item 2.05 Costs Associated wiIcebrg-12/15/2006
722Merrill: Soliris may find a broader audience Alexion reported final data from ttom pope-12/11/2006
721Alexion Pharmaceuticals' Soliris(TM) (Eculizumab) Data to be Presented at 20Icebrg-12/8/2006
720Alexion Pharmaceuticals Announces Closing of Public Offering of Stock Tuesday NoIcebrg-11/21/2006
719>>Indeed, this is not the time for a new position. I agree with you but tIRWIN JAMES FRANKEL-11/18/2006
718The AH trades are unreliable at best and misleading at worst. I have no idea whIRWIN JAMES FRANKEL-11/18/2006
717Well 8-10,000 PNH cases total in US and EU. What will Soliris price at? It hasIRWIN JAMES FRANKEL-11/18/2006
716You are not missing a thing. Indeed, this is not the time for a new position.keokalani'nui-11/18/2006
715Actually it sold off after hours, all the way to 44.91, and as far as I could tetom pope-11/17/2006
714I'm not following Alexion very closely, but my understanding is that their ltuck-11/17/2006
713With ALXN closing today significantly over 45 that means the calls will be exercIRWIN JAMES FRANKEL-11/17/2006
712OI dropped to 5577. This is like a very low close rate for one day before expiryIRWIN JAMES FRANKEL-11/17/2006
711In the money November calls strike 35,40 have open interest of 5580. Only 5 conIRWIN JAMES FRANKEL-11/16/2006
710And priced at the 52 week high, no less. Very bullish. JonRobohogs-11/15/2006
709ALXN priced and oversubscribed quickly: Alexion Pharmaceuticals Announces PriciIRWIN JAMES FRANKEL-11/15/2006
708>>Do you think they sought this deal to help cover their clients' posiIRWIN JAMES FRANKEL-11/15/2006
707>>GS is one of the bigger players in supporting the shorts.<< GS iskeokalani'nui-11/15/2006
706It may also take some of the sting out for the shorts who at last count were shoIRWIN JAMES FRANKEL-11/14/2006
705The good news is it shows the power of a strong stock. Strengthens them up as thrkrw-11/14/2006
704Alexion Pharmaceuticals Announces Proposed Public Offering of Common Stock TuesdIRWIN JAMES FRANKEL-11/14/2006
703Well there is "failed to meet the endpoint" and "<i>really&Biomaven-11/14/2006
702Looks to me like the focus of a "researcher" on his data. He is rightIRWIN JAMES FRANKEL-11/14/2006
701lol. A real head scratcher.kenhott-11/14/2006
700Agreed. It failed and alxn said they weren't pursuing. Ramifications were clrkrw-11/14/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News